Andrew Day
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Andrew Day
Andrew Day is recorded as Analyst at Jefferies. Andrew Day has spoken on 1 earnings call across 1 company, most recently for Lexicon Pharmaceuticals, Inc. on November 5, 2026. The companies whose calls Andrew Day spoke on are classified in the Healthcare sector.
Andrew Day on recent calls
“At the IHCM conference, when you guys shared the Phase III baseline patient population for Sonata in HCM, we noticed that the obstructive subgroup had a lower baseline KCCQ score compared to the two other CMI trials, suggesting a more severe symptom burden at baseline.”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current